The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...

Another popular diabetes and weight-loss drug, Ozempic (semaglutide), manufactured by Novo Nordisk, has already established a ...

The widely used anti-diabetes and weight loss drug Mounjaro, which contains the active ingredient tirzepatide, is now ...

Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...

Amy Schumer shared a health update with followers on social media, months after revealing that she'd been left bed-ridden ...

Amy Schumer opens up about her weight loss journey, sharing her experiences with Ozempic and Mounjaro, and discusses her ...

Amy Schumer has found the right weight loss medication that works for her after experiencing horrible nausea while previously ...

As research continues, Mounjaro may redefine medical weight loss strategies, but its ethical implications and long-term ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

The latest microdosing trend isn’t shrooms or acid. It’s Ozempic.

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...